GERD (Acid Reflux): The Evidence-Based Supplement Protocol

6 min read ·
Bottom Line

GERD is mainly a mechanical problem — a leaky lower esophageal sphincter and a post-meal acid pocket — so the real backbone of care is weight loss, not eating before lying down, head-of-bed elevation, and acid suppression, with supplements playing a narrow, honestly modest role. The best-evidenced add-on is an alginate-antacid “raft” (Gaviscon-type), which a meta-analysis of 14 trials found roughly quadrupled the odds of symptom relief versus placebo, though still less than a PPI; a 3 mg bedtime dose of melatonin is a plausible low-risk adjunct backed only by small, low-certainty trials. Popular options like DGL and d-limonene are essentially unproven, and magnesium belongs here only to monitor for the deficiency long-term PPIs can cause, not to treat reflux. Avoid peppermint oil and apple cider vinegar, never let supplements replace acid suppression in erosive esophagitis or Barrett’s, and get endoscopy for alarm features like trouble swallowing, weight loss, or onset after age 50.

Gastroesophageal reflux disease is driven by a mechanical problem — a leaky lower esophageal sphincter (LES) and a post-meal pocket of unbuffered acid near the junction — layered on top of acid exposure. The treatments with the strongest evidence reflect that: weight loss, not eating within three hours of lying down, head-of-bed elevation, and proton pump inhibitors (PPIs) or H2 blockers. Supplements occupy a narrow, honestly modest role: breakthrough or post-prandial symptoms, adults trying to step down from a PPI, and managing the side effects of long-term acid suppression. None of them has the trial weight of a PPI, and a frank reading of the literature is that the supplement evidence for reflux is thin and mostly low-certainty. The 2022 American College of Gastroenterology guideline frames lifestyle and acid suppression as the backbone of care and does not endorse supplements as substitutes.

Alginate "rafts" — the best-evidenced add-on

Alginate-antacid preparations (sodium alginate, e.g. Gaviscon-type products) are the one over-the-counter reflux remedy with a genuine controlled-trial base. On contact with stomach acid, alginate forms a floating gel "raft" that physically caps the post-meal acid pocket. A 2017 systematic review and meta-analysis of 14 randomized trials (2,095 subjects) found alginate-based therapy roughly quadrupled the odds of symptom resolution versus placebo or antacids (odds ratio 4.42, 95% CI 2.45–7.97), though it was less effective than PPIs. Heterogeneity was moderate-to-high and most trials were short. Practically, alginate is a reasonable as-needed layer after meals or at bedtime alongside, not instead of, standard therapy. It is a non-prescription medication rather than a dietary supplement, and we do not maintain a rating page for it.

Melatonin — small trials, low certainty

The rationale for melatonin is that gut-derived melatonin may raise LES tone and blunt acid secretion and mucosal injury. The clinical data are limited and of modest quality. A 2010 controlled trial by Kandil and colleagues enrolled just 36 people and reported that melatonin improved reflux symptoms, though omeprazole alone outperformed melatonin alone. A widely cited 2006 single-blind study (351 patients) tested a combination product — melatonin plus L-tryptophan, B6, folate, B12, methionine and betaine — against omeprazole and reported symptom regression; because it was an unblinded multi-ingredient formula, it cannot establish melatonin's independent effect. The cleanest recent evidence is a 2023 double-blind RCT (78 patients) in which adding 3 mg sublingual melatonin to omeprazole improved heartburn and symptom scores more than omeprazole plus placebo. Net read: melatonin (3 mg at bedtime) is a plausible, low-risk adjunct with small, low-certainty trials behind it — not a stand-alone treatment. See our melatonin dosing piece.

Deglycyrrhizinated licorice (DGL) and d-limonene — popular, poorly tested

Deglycyrrhizinated licorice (DGL, typically 380–400 mg chewed before meals) is a long-standing folk remedy thought to support the mucosal layer. The glycyrrhizin is removed to avoid the hypertension and hypokalemia whole licorice can cause (see our DGL explainer), so the safety profile is clean — but rigorous reflux-specific trial data are essentially absent, and most positive reports come from older, low-quality or combination studies. d-Limonene (an orange-peel oil) is marketed for reflux on the strength of tiny uncontrolled pilots and has no convincing randomized evidence. Treat both as unproven: low risk, but do not expect a PPI-sized effect.

Magnesium — for PPI side effects, not reflux itself

Magnesium does not treat reflux. Its place here is the reverse: long-term PPI use is associated with hypomagnesemia in a subset of adults, an effect the FDA flagged in a 2011 safety communication. For people on a PPI beyond a year, periodic serum magnesium testing is reasonable, with repletion if low. PPIs can also modestly impair B12 and non-heme iron absorption over years, so symptoms of deficiency warrant testing rather than blanket supplementation.

What does not work, or makes reflux worse

Avoid peppermint oil: it relaxes smooth muscle, including the LES, and can worsen reflux — the opposite of its (modest) role in IBS. Skip apple cider vinegar: there is no controlled evidence it helps reflux, and adding acid runs against any sensible mechanism. Chronic baking soda (sodium bicarbonate) risks sodium overload and metabolic alkalosis and is not a maintenance strategy. Many "stomach-soothing" herbal blends contain peppermint or carminatives that relax the LES. Most importantly, supplements must not replace acid suppression in biopsy-proven erosive esophagitis or Barrett's esophagus, where under-treatment carries real risk.

How to run the protocol

Start with the interventions that actually move outcomes: lose weight if overweight, elevate the head of the bed, stop eating 3 hours before lying down, limit alcohol and tobacco, and use a PPI or H2 blocker at the lowest effective dose under clinician guidance. Layer an alginate-antacid after meals and at bedtime for breakthrough symptoms; a 3 mg bedtime dose of melatonin is a reasonable low-risk add-on, especially when reflux disrupts sleep. Reassess at about 8 weeks. Persistent symptoms on adequate therapy, trouble swallowing, weight loss, anemia, or onset after age 50 warrant endoscopy to rule out Barrett's esophagus and eosinophilic esophagitis. If you take a PPI long term, monitor magnesium.

Sources

  1. Leiman DA, Riff BP, Morgan S, et al. "Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis." Diseases of the Esophagus, 2017;30(5):1-9. PMID 28375448 28375448.
  2. Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. "The potential therapeutic effect of melatonin in gastro-esophageal reflux disease." BMC Gastroenterology, 2010;10:7. PMID 20082715 20082715.
  3. Pereira Rde S. "Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole." Journal of Pineal Research, 2006;41(3):195-200. PMID 16948779 16948779.
  4. Malekpour H, Noori A, Abdi S, et al. "Is the addition of sublingual melatonin to omeprazole superior to omeprazole alone in the management of gastroesophageal reflux disease symptoms: a clinical trial." Turkish Journal of Gastroenterology, 2023;34(12):1206-1211. PMID 37768310 37768310.
  5. Katz PO, Gerson LB, Vela MF. "Guidelines for the diagnosis and management of gastroesophageal reflux disease." American Journal of Gastroenterology, 2013;108(3):308-328. PMID 23419381 23419381.